J, B.E., M, M.G., L, H.P., Daniel, A., Joseph, A., K, B.N., Y, C.J., G, D.C., L, D.R., S, F.D., S, H.G., Chinwe, I., R, J.L., E, J.M.K., Reading, T.M., E, T.J., & Eunice, Y. (2026). 2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.. Circulation. Population health and outcomes. https://doi.org/10.1161/HCQ.0000000000000149
J BE, M MG, L HP, Daniel A, Joseph A, K BN, et al. 2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.. Circulation. Population health and outcomes. 2026; doi: 10.1161/HCQ.0000000000000149
J BE, M MG, L HP, et al. 2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.[J]. Circulation. Population health and outcomes. 2026. DOI: 10.1161/HCQ.0000000000000149.
@article{j2026,
author = {Benjamin Emelia J and Marcus Gregory M and Hess Paul L and Addison Daniel and Akar Joseph and Brownell Nicholas K and Chyou Janice Y and Derington Catherine G and Diekemper Rebecca L and Frankel David S and Hu Gene S and Ibeh Chinwe and Jackson Larry R and Joynt Maddox Karen E and Turchioe Meghan Reading and Tisdale James E and Yang Eunice},
title = {2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.},
journal = {Circulation. Population health and outcomes},
year = {2026},
doi = {10.1161/HCQ.0000000000000149},
note = {PMID: 42607116},
}
TY - JOUR AU - Benjamin Emelia J AU - Marcus Gregory M AU - Hess Paul L AU - Addison Daniel AU - Akar Joseph AU - Brownell Nicholas K AU - Chyou Janice Y AU - Derington Catherine G AU - Diekemper Rebecca L AU - Frankel David S AU - Hu Gene S AU - Ibeh Chinwe AU - Jackson Larry R AU - Joynt Maddox Karen E AU - Turchioe Meghan Reading AU - Tisdale James E AU - Yang Eunice TI - 2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures. T2 - Circulation. Population health and outcomes PY - 2026 DO - 10.1161/HCQ.0000000000000149 AN - PMID:42607116 ER -
Atrial fibrillation (AF) is increasing in incidence, prevalence, and lifetime risk, and contributes to substantially greater health care costs and increased risks of stroke, heart failure, and mortality. Improving adherence to evidence-based recommendations equitably in AF is critical to advancing clinical care, patient outcomes, and public health. The writing committee developed a comprehensive set of 5 performance measures, which are appropriate for public reporting or pay-for-performance programs, and 16 quality measures, which are useful to clinicians and health care organizations for quality improvement. The writing committee selected the measures from the strongest recommendations (Class 1 or 3) in the "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation." The purpose of the writing committee's performance measures is meant to ensure that patients with newly diagnosed AF receive a basic clinical evaluation, with an emphasis on secondary prevention for patients at all stages of AF, documenting stroke risk, and, if indicated, providing appropriate anticoagulation. AF quality measures cover a variety of topics including measuring and addressing health inequities, optimizing antiarrhythmic or anticoagulant treatment, engaging in shared decision-making for rate- versus rhythm-control strategies, and, in appropriate patients, offering catheter ablation for those with heart failure with reduced ejection fraction. The performance and quality measures are intended to advance the quality and equity of AF care across all patient populations with AF.